How and Why MSLs Bring VALUE to an Organization

In this episode, Steven Stein, senior director of global field medical at Arena Pharmaceuticals, joins the discussion to explore the evolving role of MSLs. He delves into the concept of value within the MSL role and the strategic timing for their involvement in the drug development process. Steven emphasizes early KOL engagement, overcoming internal challenges, and neutralizing negative opinions. He shares insights on enhancing KOL relationships in a hybrid environment and offers proactive strategies for MSLs. The conversation also touches on leadership, building a legacy, and future predictions for MSLs in 2022. The episode concludes with closing remarks and expressions of gratitude.

My guest today is Steven Stein, Sr. Director, Global Field Medical Head, Arena Pharmaceuticals, and we discuss how and why MSL’s bring value to an organization.

Steven shares…

👉 How early in the drug development process should MSLs be brought into a company

👉 Different ways MSL’s bring value internally to an organization

👉 How MSL’s go about enhancing medical affairs externally

👉 Ways value is tracked or measured both internally and externally

👉 Advice for MSL leaders responsible for the strategic direction of the MSL team

👉 What 2022 will look like for MSL’s and field medical

The podcast is available through the links below:

️ ️ 〰️ Spotify: https://lnkd.in/dRrSEyn

️ ️ 〰️ Apple: https://lnkd.in/egSthAz

️ ️ 〰️ Stitcher: https://lnkd.in/eqB-2wb

📣 Now on YouTube 📣

Please subscribe: https://www.youtube.com/channel/UCS7XTUuk1XF5Tm5InADY6cA 

📣 Now on Instagram 📣

Please subscribe: 

https://www.instagram.com/msl_talk_podcast/ 

MSL Talk is a podcast that features helpful information for current Medical Science Liaisons, Medical Affairs leaders, job seekers looking to break into the pharmaceutical industry in their first MSL role as well as anyone interested in hearing good industry conversation and medical affairs discussions.

#msl #medicalaffairs #medicalscienceliaison #aspiringmsl #MSLTalk

(0:00) Introduction of guest Steven Stein, senior director of global field medical head at Arena Pharmaceuticals
(0:32) Podcast overview and social media promotion
(1:26) Steven Stein's professional background and current role
(2:47) The concept of value in the MSL role
(5:04) Optimal timing for involving MSLs in the drug development process
(8:48) Early KOL engagement and its benefits
(10:35) Internal challenges and demonstrating MSL value
(14:37) Importance of neutralizing negative opinions among KOLs
(17:20) Strategies for enhancing relationships with KOLs in a hybrid environment
(22:09) Proactive approaches and creative solutions for MSLs
(23:15) Leadership strategies for MSL leaders
(26:21) Building a legacy and inspiring your team
(26:55) Predictions for MSLs in 2022 and the hybrid model
(30:06) Closing remarks and thanks